These updates are republished press releases and communications from members of the Science|Business Network. Network Updates can be sent to [email protected] and [email protected]. To know if your content piece qualifies as Network Update, check the editorial guidelines here.

Universities turn to the middlemen

Helping UK universities turn their ideas into business has turned into a business of its own – with four IP management companies quoted on London’s Alternative Investment Market.

Biotech brings silver lining to pharma cloud

Last month the world's leading pharmaceutical company received simultaneous FDA approval for two new therapies. Yet neither drug was invented by the company. Both were originally developed by small biotechs.

Last chance for European nanomedicine

Nanotechnology has the power to transform healthcare. But Europe will lose out to the United States unless it can mount a coherent approach to developing nanomedicine, says a new report.